In this regard, MiM was noted in patients with all breast cancer subtypes, and, consistent with prior reports of MiM in other systemic malignancies,5–7,13–16 patients presented with nonspecific neurologic signs and symptoms. Here, MTSS1 is linked to breast cancer.